KMT2A and leukemia: The comparison revealed consistent trends, with BCP‐ALL and MLL‐ALL bearing the highest NLRP3 expression (Figure 4B), T‐ALL exhibiting the lowest IL‐1β expression and a persistent increase in CASP1 expression across the leukemia panel (Supporting Information S1: Figure 2).